Laura Mazzeo

8PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Context learningMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 15, 2026
Composite clinical scores in real-world extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy.

|Sep 13, 2026
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC.

|Jun 04, 2026
Alectinib and gastrointestinal perforation in ALK-rearranged non-small cell lung cancer: A case series.

|Nov 24, 2025
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.

Federica Corso, Vittoria Peppoloni, Laura Mazzeo

|Apr 16, 2024
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs.

Rita Leporati, Daniela Miliziano, Teresa Beninato

|Feb 19, 2024
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.

Luigi Cerbone, Sara Delfanti, Stefania Crivellari

Pageof 2

Frequent Collaborators

5 joint publications

Mario Occhipinti

4 joint publications

Teresa Beninato

3 joint publications

Marta Brambilla

2 joint publications

Alessandra Laura Giulia Pedrocchi